Does the FDA have regulatory authority over adult autologous stem cell therapies? 21 CFR 1271 and the emperor's new clothes

FDA has recently asserted that many autologous cell therapies once considered the practice of medicine are in fact drugs. These changes began with the creation of new sections of 21 CFR 1271 and a subsequent one word change where the FDA, without public commentary, altered a single word in its regul...

Descripción completa

Detalles Bibliográficos
Autores principales: Freeman, Michael, Fuerst, Mitchell
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3353208/
https://www.ncbi.nlm.nih.gov/pubmed/22448812
http://dx.doi.org/10.1186/1479-5876-10-60

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3353208/
https://www.ncbi.nlm.nih.gov/pubmed/22448812
http://dx.doi.org/10.1186/1479-5876-10-60

Ejemplares similares